Importer of Controlled Substances Application: Noramco Inc., 52134-52135 [2019-21320]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
52134
Federal Register / Vol. 84, No. 190 / Tuesday, October 1, 2019 / Notices
(10) If you are a U.S. importer or a
trade/business association of U.S.
importers of the Subject Merchandise
from the Subject Country, provide the
following information on your firm’s(s’)
operations on that product during
calendar year 2018 (report quantity data
in pounds and value data in U.S.
dollars). If you are a trade/business
association, provide the information, on
an aggregate basis, for the firms which
are members of your association.
(a) The quantity and value (landed,
duty-paid but not including
countervailing duties) of U.S. imports
and, if known, an estimate of the
percentage of total U.S. imports of
Subject Merchandise from the Subject
Country accounted for by your firm’s(s’)
imports;
(b) the quantity and value (f.o.b. U.S.
port, including countervailing duties) of
U.S. commercial shipments of Subject
Merchandise imported from the Subject
Country; and
(c) the quantity and value (f.o.b. U.S.
port, including countervailing duties) of
U.S. internal consumption/company
transfers of Subject Merchandise
imported from the Subject Country.
(11) If you are a producer, an exporter,
or a trade/business association of
producers or exporters of the Subject
Merchandise in the Subject Country,
provide the following information on
your firm’s(s’) operations on that
product during calendar year 2018
(report quantity data in pounds and
value data in U.S. dollars, landed and
duty-paid at the U.S. port but not
including countervailing duties). If you
are a trade/business association, provide
the information, on an aggregate basis,
for the firms which are members of your
association.
(a) Production (quantity) and, if
known, an estimate of the percentage of
total production of Subject Merchandise
in the Subject Country accounted for by
your firm’s(s’) production;
(b) Capacity (quantity) of your firm(s)
to produce the Subject Merchandise in
the Subject Country (that is, the level of
production that your establishment(s)
could reasonably have expected to
attain during the year, assuming normal
operating conditions (using equipment
and machinery in place and ready to
operate), normal operating levels (hours
per week/weeks per year), time for
downtime, maintenance, repair, and
cleanup, and a typical or representative
product mix); and
(c) the quantity and value of your
firm’s(s’) exports to the United States of
Subject Merchandise and, if known, an
estimate of the percentage of total
exports to the United States of Subject
VerDate Sep<11>2014
18:10 Sep 30, 2019
Jkt 250001
Merchandise from the Subject Country
accounted for by your firm’s(s’) exports.
(12) Identify significant changes, if
any, in the supply and demand
conditions or business cycle for the
Domestic Like Product that have
occurred in the United States or in the
market for the Subject Merchandise in
the Subject Country since the Order
Date, and significant changes, if any,
that are likely to occur within a
reasonably foreseeable time. Supply
conditions to consider include
technology; production methods;
development efforts; ability to increase
production (including the shift of
production facilities used for other
products and the use, cost, or
availability of major inputs into
production); and factors related to the
ability to shift supply among different
national markets (including barriers to
importation in foreign markets or
changes in market demand abroad).
Demand conditions to consider include
end uses and applications; the existence
and availability of substitute products;
and the level of competition among the
Domestic Like Product produced in the
United States, Subject Merchandise
produced in the Subject Country, and
such merchandise from other countries.
(13) (OPTIONAL) A statement of
whether you agree with the above
definitions of the Domestic Like Product
and Domestic Industry; if you disagree
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: This proceeding is being
conducted under authority of Title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.61 of the
Commission’s rules.
By order of the Commission.
Issued: September 20, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–20881 Filed 9–30–19; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Noramco Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 31, 2019. Such
DATES:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
persons may also file a written request
for a hearing on the application on or
before October 31, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 9, 2019, Noramco
Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801–4417
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Schedule
Marihuana .........................
Tetrahydrocannabinols .....
Nabilone ...........................
Phenylacetone ..................
Opium, raw .......................
Poppy Straw Concentrate
Tapentadol ........................
7360
7370
7379
8501
9600
9670
9780
I
I
II
II
II
II
II
The company plans to import
phenylacetone (8501), and poppy straw
concentrate (9670) to bulk manufacture
other controlled substances for
distribution to its customers. In
reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to import a synthetic
cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration. Placement of these
drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
E:\FR\FM\01OCN1.SGM
01OCN1
52135
Federal Register / Vol. 84, No. 190 / Tuesday, October 1, 2019 / Notices
Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
[FR Doc. 2019–21320 Filed 9–30–19; 8:45 am]
Bulk Manufacturer of Controlled
Substances Registration
BILLING CODE 4410–09–P
ACTION:
Notice of registration.
SUMMARY: The registrants listed below
have applied for and been granted a
Company
FR docket
Absolute Standards, Inc .............................................................................
Pisgah Laboratories, Inc ............................................................................
84 FR 31620 .......................................................
84 FR 31622 .......................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
[FR Doc. 2019–21312 Filed 9–30–19; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
18:10 Sep 30, 2019
Jkt 250001
The
companies listed below applied to be
registered as a bulk manufacturer of a
basic class of schedule I and II
controlled substances. Information on
previously published notices is listed
below. No comments or objections were
submitted for the notice.
Bulk Manufacturer of Controlled
Substances Registration; Siemens
Healthcare Diagnostics, Inc.
ACTION:
Notice of registration.
FR Docket
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each of the
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
July 2, 2019.
July 2, 2019.
Dated: September 24, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy
Assistant Administrator.
Siegfried USA, LLC ....................................................................................
Patheon Pharmaceuticals, Inc ...................................................................
S & B Pharma Inc ......................................................................................
Siemens Healthcare Diagnostics, Inc ........................................................
Synthcon, LLC ...........................................................................................
VerDate Sep<11>2014
Published
SUMMARY: The registrants listed below
have applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
registration as a bulk manufacturer to
the above listed companies.
Company
jbell on DSK3GLQ082PROD with NOTICES
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of a various classes of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as a bulk manufacturer of
various classes of scheduled I and II
controlled substances. Information on a
previously published notices is listed
below. No comments or objections were
submitted for these notices.
84
84
84
84
84
FR
FR
FR
FR
FR
Published
7129 .........................................................
8114 .........................................................
8116 .........................................................
10534 .......................................................
13962 .......................................................
March 1, 2019.
March 6, 2019.
March 6, 2019.
March 21, 2019.
April 8, 2019.
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
DEPARTMENT OF JUSTICE
Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy
Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2019–21313 Filed 9–30–19; 8:45 am]
ACTION:
Drug Enforcement Administration
Importer of Controlled Substances
Application: Noramco, Inc.
Notice of application.
BILLING CODE 4410–09–P
PO 00000
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 31, 2019. Such
persons may also file a written request
for a hearing on the application on or
before October 31, 2019.
DATES:
Frm 00076
Fmt 4703
Sfmt 4703
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Pages 52134-52135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21320]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Noramco Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before October 31, 2019.
Such persons may also file a written request for a hearing on the
application on or before October 31, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 9, 2019, Noramco Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801-4417 applied to be registered as an importer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Nabilone................................ 7379 II
Phenylacetone........................... 8501 II
Opium, raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import phenylacetone (8501), and poppy straw
concentrate (9670) to bulk manufacture other controlled substances for
distribution to its customers. In reference to drug codes 7360
(marihuana) and 7370 (THC), the company plans to import a synthetic
cannabidiol and a synthetic tetrahydrocannabinol. No other activity for
these drug codes is authorized for this registration. Placement of
these drug codes onto the company's registration does not translate
into automatic approval of subsequent permit applications to import
controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of FDA approved or non-approved finished dosage forms for commercial
sale.
[[Page 52135]]
Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21320 Filed 9-30-19; 8:45 am]
BILLING CODE 4410-09-P
